praziquantel has been researched along with Opisthorchis felineus Infection in 135 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "A clinical trial of praziquantel was carried out in patients with opisthorchiasis using low dosages with 30 and 60 days follow-up." | 9.05 | Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. ( Bunnag, D; Harinasuta, T, 1981) |
| "The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment." | 8.89 | Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis. ( Bhudhisawasdi, V; Kamsa-ard, S; Laopaiboon, M; Luvira, V, 2013) |
| " Recently, we demonstrated a persistent APF in over one-third of opisthorchiasis patients after worm removal by praziquantel (PZQ) treatment." | 8.12 | Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis. ( Deenonpoe, R; Edwards, SW; Mairiang, E; Phung, HTT; Sripa, B; Suttiprapa, S, 2022) |
| "Inflammation of the hepatobiliary system in chronic opisthorchiasis is associated with an elevated level of urinary 8-oxo-7,8 dihydro-2'deoxyguanosine (8-oxodG) during active as well as past exposure to Opisthorchis viverrini infection." | 7.91 | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. ( Bethony, JM; Chamadol, N; Eamudomkarn, C; Jumnainsong, A; Khuntikeo, N; Loilome, W; Pinlaor, S; Sithithaworn, J; Sithithaworn, P; Techasen, A; Thanan, R; Wangboon, C; Worasith, C; Yongvanit, P, 2019) |
| "It has been suggested that repeated infection of Opisthorchis viverrini followed by repeated treatment with praziquantel (PZQ) increases risk of development of cholangiocarcinoma (CCA)." | 7.85 | Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model. ( Brindley, PJ; Hanpanich, P; Laha, T; Mairiang, E; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| "This study investigated the effects of nanoencapsulated curcumin (NEC) and praziquantel (PZQ) treatment on the resolution of periductal fibrosis (PDF) and bile canalicular (BC) abnormalities in Opisthorchis viverrini infected hamsters." | 7.83 | Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters. ( Chaidee, A; Charoensuk, L; Intuyod, K; Pairojkul, C; Pinlaor, P; Pinlaor, S; Suwannateep, N; Vaeteewoottacharn, K; Wanichwecharungruang, S; Yongvanit, P, 2016) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 7.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| "The aim of this study was to investigate the apoptosis-related gene expression in hamster opisthorchiasis after praziquantel treatment." | 7.74 | Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment. ( Boonmars, T; Kaewsamut, B; Pinlaor, P; Pinlaor, S; Sithithaworn, P; Srirach, P; Srisawangwong, T; Yongvanit, P, 2008) |
| "The pharmacokinetics of praziquantel was investigated in 9 Thai male patients with asymptomatic opisthorchiasis (stool positive) and 9 patients (6 males, 3 females) with moderately advanced infection (hepatomegaly)." | 7.68 | Pharmacokinetics of praziquantel in patients with opisthorchiasis. ( Bunnag, D; Karbwang, J; Na Bangchang, K; Pungpak, S; Radomyos, B, 1993) |
| "108 patients coming to France from Southeast Asia were treated with praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin-4-one, EMBAY 8440, Biltricide) for opisthorchiasis." | 7.67 | Therapeutic results in opisthorchiasis with praziquantel in a reinfection-free environment in France. ( Ambroise-Thomas, P; Goullier, A; Peyron, F, 1984) |
| "153 patients coming to France from Southeast Asia were treated with Praziquantel for Opisthorchiasis." | 7.67 | [Praziquantel in the treatment of opisthorchiasis in Southeast Asian refugees. Evaluation of 153 cases]. ( Ambroise-Thomas, P; Goullier, A; Peyron, F; Wegner, DH, 1985) |
| "Ultrasonographic examination of the liver and biliary system using a portable ultrasound unit was performed in 1987 in 647 opisthorchiasis patients who had been treated with praziquantel during 1981 to 1986." | 7.67 | Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. ( Pungpak, S; Sornmani, S; Suntharasamai, P; Vivatanasesth, P, 1989) |
| "A clinical field trial of praziquantel was carried out in Nong Ranya Village, Amphoe Ban Phai, Khon Kaen Province, with a population of 309 individuals, and 94% prevalence rate of opisthorchiasis." | 7.67 | Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya Village, Khon Kaen Province, Thailand. ( Bunnag, D; Harinasuta, T; Kurathong, S; Upatham, S; Viravan, C; Viyanant, V, 1986) |
| "An increased efficacy of liposomes-encapsulated praziquantel was observed in the treatment of hamster opisthorchiasis." | 7.66 | Increased efficacy of liposomes-encapsulated praziquantel in treatment of opisthorchiasis in hamsters. ( Ruenwongsa, P; Thamavit, W, 1983) |
| " Thus, the effective treatment dose of PZQ, as well as its adverse effects, was evaluated in O." | 6.84 | Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis. ( Mallory, FF; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| "Ninety-six patients who had heavy Opisthorchis viverrini infection were studied." | 6.66 | Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. ( Bunnag, D; Harinasuta, T; Pungpak, S, 1985) |
| "Praziquantel (Embay 8440) was found to be effective in eliminating egg of Opishtorchis viverrini." | 6.65 | Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. ( Bunnag, D; Harinasuta, T, 1980) |
| "In a study, gallbladder lesions due to Opisthorchis viverrini infection were controlled roentgenographically after treatment with praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin- 4-one, EMBAY 8440, Biltricide)." | 5.27 | Roentgenographically controlled healing of gallbladder lesions in opisthorchiasis after praziquantel treatment. ( Bunnag, D; Dhiensiri, T; Eua-Ananta, Y; Harinasuta, T; Schelp, PF, 1984) |
| "Sixty cases of Opisthorchis viverrini infection were treated with Praziquantel, 3 x 25 mg/kg body weight for one day, except one case that was retreated with the same regimen at one month after the first treatment, and the cure rate was 100." | 5.26 | Field trial of praziquantel in human opisthorchiasis in Thailand. ( Pawabut, P; Supanvanich, K; Supanvanich, S, 1981) |
| " These patients received Praziquantel in a dosage of 20 mg/kg bwt." | 5.26 | Praziquantel in clonorchiasis and opisthorchiasis. ( Lang, W; Löscher, T; Nothdurft, HD; Prüfer, L; von Sonnenburg, F, 1981) |
| "Praziquantel shows high efficacy against clonorchiasis and opisthorchiasis." | 5.22 | Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. ( Keiser, J; Palmeirim, MS; Patel, C; Qian, MB; Schindler, C; Utzinger, J; Wang, X; Zhou, XN, 2022) |
| "A clinical trial of praziquantel was carried out in patients with opisthorchiasis using low dosages with 30 and 60 days follow-up." | 5.05 | Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel. ( Bunnag, D; Harinasuta, T, 1981) |
| "The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment." | 4.89 | Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis. ( Bhudhisawasdi, V; Kamsa-ard, S; Laopaiboon, M; Luvira, V, 2013) |
| " The cure rates of opisthorchiasis at 1 month post-praziquantel treatment determined by urinary OV-RDT (86." | 4.31 | Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. ( Andrews, RH; Homwong, C; Khongsukwiwat, K; Kopolrat, KY; Laha, T; Loilome, W; Namwat, N; Sithithaworn, J; Sithithaworn, P; Tawarungruang, C; Taylor-Robinson, SD; Techasen, A; Thinkamrop, B; Titapun, A; Wongphutorn, P; Worasith, C, 2023) |
| " Recently, we demonstrated a persistent APF in over one-third of opisthorchiasis patients after worm removal by praziquantel (PZQ) treatment." | 4.12 | Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis. ( Deenonpoe, R; Edwards, SW; Mairiang, E; Phung, HTT; Sripa, B; Suttiprapa, S, 2022) |
| "Racemic praziquantel (PZQ) is the standard treatment for schistosomiasis and liver fluke infections (opisthorchiasis and clonorchiasis)." | 4.12 | R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini. ( Coulibaly, J; Falcoz, C; Guzy, S; Keiser, J; Kovač, J; Lin, YW; Meister, I; Sayasone, S; Wesche, D, 2022) |
| " The participants with advanced periductal fibrosis (APF) by ultrasound (n = 785) were invited to undergo annual follow-up ultrasonography for five years after praziquantel treatment." | 4.02 | Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study. ( Bethony, J; Brindley, PJ; Kaewkes, S; Laha, T; Loukas, A; Mairiang, E; Sripa, B, 2021) |
| " The main drug used in treatment of opisthorchiasis and other trematode and cestode infestations is praziquantel (PZQ)." | 3.96 | Opisthorchis felineus genes differentially expressed under praziquantel shed light on the nature of tegument disruption and indicate the adaptive role of cGMP-dependent protein kinase. ( Katokhin, A; Pirozhkova, D, 2020) |
| "Inflammation of the hepatobiliary system in chronic opisthorchiasis is associated with an elevated level of urinary 8-oxo-7,8 dihydro-2'deoxyguanosine (8-oxodG) during active as well as past exposure to Opisthorchis viverrini infection." | 3.91 | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. ( Bethony, JM; Chamadol, N; Eamudomkarn, C; Jumnainsong, A; Khuntikeo, N; Loilome, W; Pinlaor, S; Sithithaworn, J; Sithithaworn, P; Techasen, A; Thanan, R; Wangboon, C; Worasith, C; Yongvanit, P, 2019) |
| "It has been suggested that repeated infection of Opisthorchis viverrini followed by repeated treatment with praziquantel (PZQ) increases risk of development of cholangiocarcinoma (CCA)." | 3.85 | Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model. ( Brindley, PJ; Hanpanich, P; Laha, T; Mairiang, E; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| " Aspirin has many properties including anti-inflammation and anti-cancer." | 3.83 | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. ( Aukkanimart, R; Boonmars, T; Jiraporn, S; Loilome, W; Nadchanan, W; Namwat, N; Ruangjirachuporn, W; Sriraj, P; Sudsarn, P, 2016) |
| "This study investigated the effects of nanoencapsulated curcumin (NEC) and praziquantel (PZQ) treatment on the resolution of periductal fibrosis (PDF) and bile canalicular (BC) abnormalities in Opisthorchis viverrini infected hamsters." | 3.83 | Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters. ( Chaidee, A; Charoensuk, L; Intuyod, K; Pairojkul, C; Pinlaor, P; Pinlaor, S; Suwannateep, N; Vaeteewoottacharn, K; Wanichwecharungruang, S; Yongvanit, P, 2016) |
| " Praziquantel (PZQ) is the drug of choice for the treatment of opisthorchiasis, but the effects of this drug on O." | 3.81 | The first comprehensive study of praziquantel effects in vivo and in vitro on European liver fluke Opisthorchis felineus (Trematoda). ( Katokhin, AV; Mordvinov, VA; Pakharukova, MY; Pirozhkova, DS; Shilov, AG, 2015) |
| "Opisthorchiasis, caused by the liver fluke Opisthorchis viverrini, a food-borne trematode, is an important public health problem; however, only a single drug, praziquantel is available." | 3.79 | Activity of tribendimidine and praziquantel combination therapy against the liver fluke Opisthorchis viverrini in vitro and in vivo. ( Adelfio, R; Keiser, J; Odermatt, P; Tesana, S; Vargas, M, 2013) |
| " Treatment of opisthorchiasis patients with praziquantel, an anti- trematode drug was shown to reduce inflammation-mediated tissue damage and carcinogenesis." | 3.78 | Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. ( Bartsch, H; Pinlaor, S; Yongvanit, P, 2012) |
| "Our objective was to reveal whether host immune response in hamster opisthorchiasis post-praziquantel treatment could induce apoptotic cell death in inflammatory cells." | 3.74 | Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. ( Boonmars, T; Kaewsamut, B; Pinlaor, S; Sithithaworn, P; Srirach, P; Srisawangwong, T, 2007) |
| "The aim of this study was to investigate the apoptosis-related gene expression in hamster opisthorchiasis after praziquantel treatment." | 3.74 | Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment. ( Boonmars, T; Kaewsamut, B; Pinlaor, P; Pinlaor, S; Sithithaworn, P; Srirach, P; Srisawangwong, T; Yongvanit, P, 2008) |
| "The purpose of this study was to examine in vivo the activity of cytochrome P450 (CYP) 2A6, an enzyme capable of activating carcinogens, including N-nitrosodimethylamine, in humans with the carcinogenic liver fluke infection, opisthorchiasis viverrini, before and after treatment with the antiparasitic agent, praziquantel." | 3.69 | Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini. ( Bartsch, H; Haswell-Elkins, MR; Lang, MA; Mairiang, E; Mairiang, P; Pelkonen, P; Satarug, S; Sithithaworn, P; Yongvanit, P, 1996) |
| "The pharmacokinetics of praziquantel was investigated in 9 Thai male patients with asymptomatic opisthorchiasis (stool positive) and 9 patients (6 males, 3 females) with moderately advanced infection (hepatomegaly)." | 3.68 | Pharmacokinetics of praziquantel in patients with opisthorchiasis. ( Bunnag, D; Karbwang, J; Na Bangchang, K; Pungpak, S; Radomyos, B, 1993) |
| "Dilution-sedimentation examination of stool specimens from four opisthorchiasis patients treated with praziquantel led to the discovery of six Plagiorchis worms." | 3.67 | A new intestinal fluke, Plagiorchis harinasutai n.sp. ( Bunnag, D; Harinasuta, T; Radomyos, P, 1989) |
| "A clinical field trial of praziquantel was carried out in Nong Ranya Village, Amphoe Ban Phai, Khon Kaen Province, with a population of 309 individuals, and 94% prevalence rate of opisthorchiasis." | 3.67 | Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya Village, Khon Kaen Province, Thailand. ( Bunnag, D; Harinasuta, T; Kurathong, S; Upatham, S; Viravan, C; Viyanant, V, 1986) |
| "Ultrasonographic examination of the liver and biliary system using a portable ultrasound unit was performed in 1987 in 647 opisthorchiasis patients who had been treated with praziquantel during 1981 to 1986." | 3.67 | Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. ( Pungpak, S; Sornmani, S; Suntharasamai, P; Vivatanasesth, P, 1989) |
| "108 patients coming to France from Southeast Asia were treated with praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin-4-one, EMBAY 8440, Biltricide) for opisthorchiasis." | 3.67 | Therapeutic results in opisthorchiasis with praziquantel in a reinfection-free environment in France. ( Ambroise-Thomas, P; Goullier, A; Peyron, F, 1984) |
| "153 patients coming to France from Southeast Asia were treated with Praziquantel for Opisthorchiasis." | 3.67 | [Praziquantel in the treatment of opisthorchiasis in Southeast Asian refugees. Evaluation of 153 cases]. ( Ambroise-Thomas, P; Goullier, A; Peyron, F; Wegner, DH, 1985) |
| "An increased efficacy of liposomes-encapsulated praziquantel was observed in the treatment of hamster opisthorchiasis." | 3.66 | Increased efficacy of liposomes-encapsulated praziquantel in treatment of opisthorchiasis in hamsters. ( Ruenwongsa, P; Thamavit, W, 1983) |
| "In an attempt to control opisthorchiasis, a single dose of 40 mg/kg of Praziquantel was given to 666 people in the three villages of Nam Pong Water Resource Development Project, Khon Kaen, Northeast Thailand." | 3.66 | Mass treatment of opisthorchiasis in Northeast Thailand. ( Harinasuta, C; Impand, P; Preuksaraj, S; Schelp, FP; Sitabutra, P; Sornmani, S; Vivatanasesth, P, 1982) |
| "41 patients (20 females and 21 males aged from 8 to 68 years) were prescribed 2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one(praziquantel, EMBAY 8440, Biltricide) at a dose of 25 mg/kg body weight given three times on a single day at intervals of 4 h, for the treatment of opisthorchiasis." | 3.66 | [Study on the tolerability of high doses of praziquantel in Laotians with parasitic liver infections (author's transl)]. ( Ambroise-Thomas, P; Goullier, A, 1981) |
| " However, tribendimidine has a similar egg reduction rate to praziquantel and leads to fewer adverse events and thus might complement praziquantel in O viverrini control programmes, particularly in settings co-endemic for hookworm." | 2.87 | Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. ( Hattendorf, J; Keiser, J; Meister, I; Odermatt, P; Phongluxa, K; Sayasone, S; Senggnam, K; Vonghachack, Y; Xayavong, S, 2018) |
| " Adverse events were recorded at baseline, 3 hours, and 24 hours posttreatment." | 2.84 | Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial. ( Andrews, JR; Bogoch, II; Hattendorf, J; Keiser, J; Meister, I; Odermatt, P; Phongluxa, K; Sayasone, S; Senggnam, K; Vonghachack, Y; Xayavong, S, 2017) |
| " Thus, the effective treatment dose of PZQ, as well as its adverse effects, was evaluated in O." | 2.84 | Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis. ( Mallory, FF; Sereerak, P; Sripa, B; Tangkawattana, P; Tangkawattana, S; Upontain, S, 2017) |
| "Schistosomiasis and opisthorchiasis are of public health importance in Southeast Asia." | 2.77 | Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. ( Akkhavong, K; Ayé Soukhathammavong, P; Hatz, C; Keiser, J; Lovis, L; Mak, TK; Odermatt, P; Phongluxa, K; Tanner, M; Utzinger, J; Vonghachack, Y; Vounatsou, P, 2012) |
| " Most adverse events were mild or moderate and affected all treatment groups; serious adverse events--vertigo, nausea, vomiting, and anxiety--were reported only by patients taking mefloquine or mefloquine-artesunate." | 2.76 | Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. ( Akkhavong, K; Hatz, C; Keiser, J; Odermatt, P; Sayasone, S; Soukhathammavong, P; Vonghachack, Y; Vounatsou, P, 2011) |
| "Ninety-six patients who had heavy Opisthorchis viverrini infection were studied." | 2.66 | Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection. ( Bunnag, D; Harinasuta, T; Pungpak, S, 1985) |
| "Praziquantel (Embay 8440) was found to be effective in eliminating egg of Opishtorchis viverrini." | 2.65 | Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. ( Bunnag, D; Harinasuta, T, 1980) |
| "Praziquantel is a treatment of choice not only for humans but also for animal reservoirs." | 2.58 | Reservoir Animals and Their Roles in Transmission of Opisthorchis viverrini. ( Tangkawattana, P; Tangkawattana, S, 2018) |
| "Opisthorchis viverrini infection is an emerging disease in Cambodia, especially in central and southeastern areas." | 1.91 | High endemicity of Opisthorchis viverrini infection among people in northern Cambodia confirmed by adult worm expulsion. ( Chai, JY; Chang, T; Cho, J; Hong, S; Hong, SJ; Huy, R; Jung, BK; Khieu, V; Lee, J; Lee, KH; Ryoo, S; Sohn, WM, 2023) |
| "For decades, treatment of opisthorchiasis has been based on praziquantel." | 1.51 | A study of tribendimidine effects in vitro and in vivo on the liver fluke Opisthorchis felineus. ( Mordvinov, VA; Pakharukova, MY; Samsonov, VA; Serbina, EA, 2019) |
| "Opisthorchis viverrini infection is highly prevalent in northeast Thailand." | 1.51 | Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand. ( Gray, DJ; Kelly, MJ; Khuntikeo, N; Sithithaworn, P; Suwannatrai, AT; Thinkhamrop, K; Thinkhamrop, W; Wangdi, K, 2019) |
| " According to the pharmacokinetic data, the use of the composition increased the bioavailability of praziquantel 3 times." | 1.48 | Physicochemical Properties and Anti-Opisthorchosis Effect of Mechanochemically Synthesized Solid Compositions of Praziquantel with Glycyrrhizic Acid Disodium Salt. ( Avgustinovich, DF; Chistyachenko, YS; Dushkin, AV; Khvostov, MV; Lyakhov, NZ; Meteleva, ES; Mordvinov, VA; Polyakov, NE; Suntsova, LP; Tolstikova, TG; Tsyganov, MA; Vishnivetskaya, GB, 2018) |
| "Opisthorchiasis is a serious human and fish-eating animal's disease affecting bile ducts and the gall bladder." | 1.48 | Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro. ( Mordvinov, VA; Pakharukov, YV; Pakharukova, MY, 2018) |
| "Praziquantel (PZQ) is the treatment of choice for infections with the liver fluke Opisthorchis viverrini, a major health problem in Southeast Asia." | 1.43 | Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients. ( Duthaler, U; Huwyler, J; Keiser, J; Kovac, J; Meister, I; Odermatt, P; Sayasone, S; Vanobberghen, F, 2016) |
| " Since many people are aware that dosing with praziquantel (PZQ) is a successful treatment for an episode of the infection, there is a risk that, to avoid the long term consequences, they will engage in a cycle of infection, dosing and reinfection." | 1.43 | Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel. ( Bradshaw, P; Promthet, S; Saengsawang, P, 2016) |
| "Opisthorchis viverrini infection is a serious public health problem in Southeast Asia especially in the northeast and north of Thailand." | 1.42 | The Carcinogenic Liver Fluke Opisthorchis viverrini among Rural Community People in Northeast Thailand: a Cross- Sectional Descriptive Study using Multistage Sampling Technique. ( Kaewpitoon, N; Kaewpitoon, SJ; Matrakool, L; Rujirakul, R; Tongtawee, T; Ueng-Arporn, N, 2015) |
| "This reason for jaundice is highly unusual in Europe." | 1.40 | [A man in his thirties with icterus and itching]. ( Brekke, H; Holmberg, M; Huppertz-Hauss, G; Skudal, H, 2014) |
| "Praziquantel treatment in Opisthorchis viverrini-infected patients reduces the hepatobiliary fibrosis due to tissue resorption, however, some fibroses are irreversible." | 1.35 | Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection. ( Boonmars, T; Hiraku, Y; Pinlaor, P; Pinlaor, S; Prakobwong, S; Wongkham, C, 2009) |
| "Opisthorchiasis is common to eastern Europe and areas of the former Soviet Union, but extremely rare in Greece." | 1.32 | A case of Opisthorchis felineus infestation in a pilot from Greece. ( Kotsakis, P; Mantadakis, E; Papoulis, S; Samonis, G; Tselepatiotis, E; Vassalou, E, 2003) |
| "Chronic opisthorchiasis is treated in three stages: preparation measures, specific chemotherapy, rehabilitation." | 1.32 | [Clinical picture, diagnosis and treatment of chronic opisthorchiasis]. ( Pal'tsev, AI, 2003) |
| "The prevalence of opisthorchiasis is 18." | 1.30 | The impact of a decade long opisthorchiasis control program in northeastern Thailand. ( Imsomboon, T; Jongsuksuntigul, P, 1997) |
| "Clonorchiasis and opisthorchiasis are snail-transmitted trematode infections." | 1.29 | Clonorchiasis/opisthorchiasis in Malaysians case reports and review. ( Lee, SH; Nazarina, AR; Pathmanathan, R; Shekhar, KC, 1995) |
| "), each time approximately 5 weeks after dosing with 60-80 OV metacercariae at weeks 0, 8, 16, 24 and 32." | 1.28 | Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential. ( Ito, N; Moore, MA; Ruchirawat, S; Thamavit, W, 1992) |
| " Side effects were mild and transient and were more frequent in higher dosage groups." | 1.27 | Opisthorchis viverrini: clinical experience with praziquantel in Hospital for Tropical Diseases. ( Bunnag, D; Charoenlarp, P; Harinasuta, T; LooAreesuwan, S; Migasena, S; Pungpark, S; Riganti, M; Suntharasamai, P; Vanijanonta, S; Viravan, C, 1984) |
| "In a study, gallbladder lesions due to Opisthorchis viverrini infection were controlled roentgenographically after treatment with praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a] isoquinolin- 4-one, EMBAY 8440, Biltricide)." | 1.27 | Roentgenographically controlled healing of gallbladder lesions in opisthorchiasis after praziquantel treatment. ( Bunnag, D; Dhiensiri, T; Eua-Ananta, Y; Harinasuta, T; Schelp, PF, 1984) |
| "Sixty cases of Opisthorchis viverrini infection were treated with Praziquantel, 3 x 25 mg/kg body weight for one day, except one case that was retreated with the same regimen at one month after the first treatment, and the cure rate was 100." | 1.26 | Field trial of praziquantel in human opisthorchiasis in Thailand. ( Pawabut, P; Supanvanich, K; Supanvanich, S, 1981) |
| "Praziquantel proved to be a safe and effective drug for therapy of Clonorchis/Opisthorchis infections." | 1.26 | High efficacy of praziquantel in the treatment of 22 patients with Clonorchis/Opisthorchis infections. ( Dietrich, M; Feldheim, W; Feldmeier, H; Horstmann, RD, 1981) |
| " These patients received Praziquantel in a dosage of 20 mg/kg bwt." | 1.26 | Praziquantel in clonorchiasis and opisthorchiasis. ( Lang, W; Löscher, T; Nothdurft, HD; Prüfer, L; von Sonnenburg, F, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (27.41) | 18.7374 |
| 1990's | 26 (19.26) | 18.2507 |
| 2000's | 17 (12.59) | 29.6817 |
| 2010's | 41 (30.37) | 24.3611 |
| 2020's | 14 (10.37) | 2.80 |
| Authors | Studies |
|---|---|
| Falcoz, C | 1 |
| Guzy, S | 1 |
| Kovač, J | 2 |
| Meister, I | 4 |
| Coulibaly, J | 1 |
| Sayasone, S | 5 |
| Wesche, D | 1 |
| Lin, YW | 1 |
| Keiser, J | 8 |
| Phung, HTT | 1 |
| Deenonpoe, R | 2 |
| Suttiprapa, S | 2 |
| Mairiang, E | 10 |
| Edwards, SW | 1 |
| Sripa, B | 9 |
| Qian, MB | 1 |
| Patel, C | 1 |
| Palmeirim, MS | 1 |
| Wang, X | 1 |
| Schindler, C | 1 |
| Utzinger, J | 2 |
| Zhou, XN | 1 |
| Jung, BK | 1 |
| Hong, S | 1 |
| Chang, T | 1 |
| Cho, J | 1 |
| Ryoo, S | 1 |
| Lee, KH | 1 |
| Lee, J | 1 |
| Sohn, WM | 3 |
| Hong, SJ | 1 |
| Khieu, V | 1 |
| Huy, R | 1 |
| Chai, JY | 3 |
| Worasith, C | 4 |
| Sithithaworn, J | 4 |
| Wongphutorn, P | 1 |
| Homwong, C | 2 |
| Khongsukwiwat, K | 1 |
| Techasen, A | 3 |
| Kopolrat, KY | 2 |
| Loilome, W | 4 |
| Namwat, N | 2 |
| Thinkamrop, B | 1 |
| Tawarungruang, C | 1 |
| Titapun, A | 1 |
| Laha, T | 4 |
| Andrews, RH | 1 |
| Taylor-Robinson, SD | 1 |
| Sithithaworn, P | 13 |
| Muthukumar, R | 1 |
| Kessomboon, P | 1 |
| Smith, JF | 1 |
| Vale, N | 1 |
| Gouveia, MJ | 1 |
| Gärtner, F | 1 |
| Pirozhkova, D | 1 |
| Katokhin, A | 1 |
| Pengput, A | 1 |
| Schwartz, DG | 1 |
| Wangboon, C | 3 |
| Thanan, R | 4 |
| Khuntikeo, N | 5 |
| Prakobwong, S | 2 |
| Suwannatrai, K | 1 |
| Sokolova, TS | 1 |
| Petrov, VA | 1 |
| Saltykova, IV | 1 |
| Dorofeeva, YB | 1 |
| Tyakht, AV | 1 |
| Ogorodova, LM | 1 |
| Fedorova, OS | 1 |
| Kaewkes, S | 2 |
| Loukas, A | 2 |
| Bethony, J | 1 |
| Brindley, PJ | 3 |
| Songserm, N | 1 |
| Namwong, W | 1 |
| Woradet, S | 1 |
| Ali, A | 1 |
| Vonghachack, Y | 4 |
| Xayavong, S | 2 |
| Senggnam, K | 2 |
| Phongluxa, K | 4 |
| Hattendorf, J | 2 |
| Odermatt, P | 7 |
| Yongvanit, P | 11 |
| Eamudomkarn, C | 2 |
| Chamadol, N | 3 |
| Saichua, P | 1 |
| Bethony, JM | 2 |
| Pakharukova, MY | 3 |
| Pakharukov, YV | 1 |
| Mordvinov, VA | 4 |
| Tangkawattana, S | 3 |
| Tangkawattana, P | 3 |
| Meteleva, ES | 1 |
| Chistyachenko, YS | 1 |
| Suntsova, LP | 1 |
| Tsyganov, MA | 1 |
| Vishnivetskaya, GB | 1 |
| Avgustinovich, DF | 1 |
| Khvostov, MV | 1 |
| Polyakov, NE | 1 |
| Tolstikova, TG | 1 |
| Dushkin, AV | 1 |
| Lyakhov, NZ | 1 |
| Pinlaor, S | 9 |
| Jumnainsong, A | 1 |
| Samsonov, VA | 1 |
| Serbina, EA | 1 |
| Avgustinovich, D | 1 |
| Tsyganov, M | 1 |
| Vishnivetskaya, G | 1 |
| Kovner, A | 1 |
| Sorokina, I | 1 |
| Orlovskaya, I | 1 |
| Toporkova, L | 1 |
| Goiman, E | 1 |
| Tolstikova, T | 1 |
| Dushkin, A | 1 |
| Lyakhov, N | 1 |
| Mordvinov, V | 1 |
| Thinkhamrop, K | 1 |
| Thinkhamrop, W | 1 |
| Wangdi, K | 1 |
| Kelly, MJ | 1 |
| Suwannatrai, AT | 1 |
| Gray, DJ | 1 |
| Grigor'eva, IN | 1 |
| Saengsawang, P | 2 |
| Promthet, S | 2 |
| Bradshaw, P | 2 |
| Wonkchalee, N | 1 |
| Boonmars, T | 5 |
| Laummaunwai, P | 1 |
| Aromdee, C | 1 |
| Hahnvajanawong, C | 1 |
| Wu, Z | 1 |
| Sriraj, P | 2 |
| Aukkanimart, R | 2 |
| Chamgramol, Y | 2 |
| Pairojkul, C | 3 |
| Juasook, A | 1 |
| Sudsarn, P | 2 |
| Kamsa-ard, S | 1 |
| Laopaiboon, M | 1 |
| Luvira, V | 1 |
| Bhudhisawasdi, V | 1 |
| Kapliuk, AA | 1 |
| Gorlenko, LV | 1 |
| Filippov, GP | 1 |
| Kovalev, IA | 1 |
| Romantsov, MG | 1 |
| Wunderink, HF | 1 |
| Rozemeijer, W | 1 |
| Rozemijer, W | 1 |
| Wever, PC | 1 |
| Verweij, JJ | 1 |
| van Lieshout, L | 1 |
| van Eeuwijk, P | 1 |
| Soukhathammavong, PA | 1 |
| Akkhavong, K | 3 |
| Huppertz-Hauss, G | 1 |
| Brekke, H | 1 |
| Holmberg, M | 1 |
| Skudal, H | 1 |
| Chomvarin, C | 1 |
| Shilov, AG | 1 |
| Pirozhkova, DS | 1 |
| Katokhin, AV | 1 |
| Ruangjirachuporn, W | 1 |
| Nadchanan, W | 1 |
| Jiraporn, S | 1 |
| Charoensuk, L | 1 |
| Pinlaor, P | 3 |
| Wanichwecharungruang, S | 1 |
| Intuyod, K | 1 |
| Vaeteewoottacharn, K | 1 |
| Chaidee, A | 1 |
| Suwannateep, N | 1 |
| Kaewpitoon, SJ | 1 |
| Kaewpitoon, N | 1 |
| Rujirakul, R | 1 |
| Ueng-Arporn, N | 1 |
| Matrakool, L | 1 |
| Tongtawee, T | 1 |
| Hanpanich, P | 1 |
| Sereerak, P | 2 |
| Upontain, S | 2 |
| Duthaler, U | 1 |
| Huwyler, J | 1 |
| Vanobberghen, F | 1 |
| Echaubard, P | 1 |
| Mallory, FF | 2 |
| Wilcox, BA | 1 |
| Andrews, JR | 1 |
| Bogoch, II | 1 |
| Dechakhamphu, S | 2 |
| Nair, J | 2 |
| Sitthithaworn, P | 2 |
| Bartsch, H | 4 |
| Wongkham, C | 1 |
| Hiraku, Y | 2 |
| Korkin, AL | 1 |
| Akhmedov, VA | 1 |
| Kritevich, MA | 1 |
| Ostapenko, VA | 1 |
| Sokolova, TF | 1 |
| Sato, M | 1 |
| Pongvongsa, T | 1 |
| Sanguankiat, S | 1 |
| Yoonuan, T | 1 |
| Dekumyoy, P | 1 |
| Kalambaheti, T | 1 |
| Keomoungkhoun, M | 1 |
| Phimmayoi, I | 1 |
| Boupha, B | 1 |
| Moji, K | 1 |
| Waikagul, J | 1 |
| Schuster, RK | 1 |
| Tappe, D | 1 |
| Triefenbach, R | 1 |
| Soukhathammavong, P | 1 |
| Vounatsou, P | 2 |
| Hatz, C | 2 |
| Shin, EH | 2 |
| Yong, TS | 2 |
| Eom, KS | 2 |
| Jeong, HG | 1 |
| Sinuon, M | 1 |
| Socheat, D | 1 |
| Teeratantikanont, M | 1 |
| Traverso, A | 1 |
| Repetto, E | 1 |
| Magnani, S | 1 |
| Meloni, T | 1 |
| Natrella, M | 1 |
| Marchisio, P | 1 |
| Giacomazzi, C | 1 |
| Bernardi, P | 1 |
| Gatti, S | 1 |
| Gomez Morales, MA | 1 |
| Pozio, E | 2 |
| Lovis, L | 1 |
| Mak, TK | 1 |
| Ayé Soukhathammavong, P | 1 |
| Tanner, M | 1 |
| Adelfio, R | 1 |
| Vargas, M | 1 |
| Tesana, S | 2 |
| Chemich, ND | 1 |
| Zakhlebaeva, VV | 1 |
| Il'ina, NI | 1 |
| Armignacco, O | 1 |
| Ferri, F | 1 |
| Gomez-Morales, MA | 1 |
| Caterini, L | 1 |
| Chuĭkova, KI | 1 |
| Pal'tsev, AI | 1 |
| Mairiang, P | 5 |
| Jongsuksuntigul, P | 3 |
| Imsomboon, T | 2 |
| Tselepatiotis, E | 1 |
| Mantadakis, E | 1 |
| Papoulis, S | 1 |
| Vassalou, E | 1 |
| Kotsakis, P | 1 |
| Samonis, G | 1 |
| Yossepowitch, O | 1 |
| Gotesman, T | 1 |
| Assous, M | 1 |
| Marva, E | 1 |
| Zimlichman, R | 1 |
| Dan, M | 1 |
| Park, JH | 1 |
| Han, ET | 1 |
| Guk, SM | 1 |
| Lin, A | 1 |
| Kim, JL | 1 |
| Min, DY | 1 |
| Hwang, EH | 1 |
| Phommmasack, B | 1 |
| Insisiengmay, B | 1 |
| Rim, HJ | 1 |
| Strandgaard, H | 1 |
| Johansen, MV | 1 |
| Montresor, A | 1 |
| Ørnbjerg, N | 1 |
| Srisawangwong, T | 2 |
| Srirach, P | 2 |
| Kaewsamut, B | 2 |
| Murata, M | 1 |
| Tangkanakul, W | 1 |
| Oikawa, S | 1 |
| Kawanishi, S | 1 |
| Hutadilok, N | 1 |
| Thamavit, W | 6 |
| Upatham, ES | 3 |
| Ruenwongsa, P | 3 |
| Tawatsin, A | 1 |
| Sirisinha, S | 5 |
| Vajrasthira, S | 1 |
| Bunnag, D | 19 |
| Harinasuta, T | 14 |
| Webbe, G | 1 |
| Sornmani, S | 4 |
| Vivatanasesth, P | 4 |
| Impand, P | 3 |
| Phatihatakorn, W | 1 |
| Sitabutra, P | 3 |
| Schelp, FP | 4 |
| Pungpark, S | 1 |
| Viravan, C | 3 |
| Vanijanonta, S | 1 |
| Suntharasamai, P | 2 |
| Migasena, S | 1 |
| Charoenlarp, P | 1 |
| Riganti, M | 2 |
| LooAreesuwan, S | 1 |
| Dhiensiri, T | 1 |
| Eua-Ananta, Y | 1 |
| Schelp, PF | 1 |
| Ambroise-Thomas, P | 4 |
| Goullier, A | 4 |
| Peyron, F | 2 |
| Patihatakorn, W | 1 |
| Worasan, P | 1 |
| Preuksaraj, S | 2 |
| Noblet, GP | 1 |
| Hunter, WH | 1 |
| Hutradilok, N | 1 |
| Pungpak, S | 11 |
| Puengtomwatanakul, S | 1 |
| Sobhon, P | 1 |
| Saitongdee, P | 1 |
| Wongpayabal, P | 1 |
| Mitranonde, V | 1 |
| Radomyos, P | 7 |
| Harinasuta, C | 1 |
| Ziegler, K | 1 |
| Moeller, FW | 1 |
| Lafrenz, M | 1 |
| Bonnet-Eymard, J | 1 |
| Fournet, J | 1 |
| Supanvanich, S | 1 |
| Supanvanich, K | 1 |
| Pawabut, P | 1 |
| Horstmann, RD | 1 |
| Feldheim, W | 1 |
| Feldmeier, H | 1 |
| Dietrich, M | 1 |
| Löscher, T | 2 |
| Nothdurft, HD | 1 |
| Prüfer, L | 1 |
| von Sonnenburg, F | 1 |
| Lang, W | 1 |
| Haswell-Elkins, MR | 4 |
| Satarug, S | 3 |
| Tsuda, M | 2 |
| Esumi, H | 2 |
| Saitoh, M | 1 |
| Elkins, DB | 4 |
| Shekhar, KC | 1 |
| Nazarina, AR | 1 |
| Lee, SH | 1 |
| Pathmanathan, R | 1 |
| Jelinek, T | 1 |
| Sauer, FJ | 1 |
| Steinhardt, HJ | 1 |
| Ruangkunaporn, Y | 2 |
| Akai, PS | 3 |
| Chongsa-nguan, M | 2 |
| Sri-Yeythong, S | 1 |
| Kitikoon, V | 4 |
| Chaicumpa, W | 4 |
| Radomyos, B | 4 |
| Tungtrongchitr, A | 1 |
| Na Bangchang, K | 1 |
| Karbwang, J | 1 |
| Hinz, E | 1 |
| Saowakontha, S | 2 |
| Pipitgool, V | 2 |
| Zhukov, NA | 1 |
| Klimova, SK | 1 |
| Keystone, JS | 1 |
| Moore, MA | 3 |
| Shirai, T | 1 |
| Ito, N | 3 |
| Pariyanonda, S | 1 |
| Rojsathaporn, K | 1 |
| Intarakhao, C | 1 |
| Befus, AD | 2 |
| Sukprasert, S | 1 |
| Chaiyakum, J | 1 |
| Loapaiboon, V | 1 |
| Lang, MA | 1 |
| Pelkonen, P | 1 |
| Chalermrut, K | 1 |
| Yemput, C | 1 |
| Plooksawasdi, W | 1 |
| Ho, M | 1 |
| Wongsaroj, T | 2 |
| Wilairatana, P | 1 |
| Praevanich, R | 1 |
| Meesomboon, V | 1 |
| Jongsuksuntikul, P | 1 |
| Radomyos, BE | 1 |
| Tiwawech, D | 1 |
| Tsuda, H | 1 |
| Sakolvaree, Y | 1 |
| Maleewong, W | 1 |
| Tapchaisri, P | 1 |
| Cross, JH | 1 |
| Sukontason, KL | 1 |
| Sukontason, K | 1 |
| Piangjai, S | 1 |
| Kashuba, EA | 1 |
| Rusakova, LI | 1 |
| Cherdron, A | 1 |
| Fiegel, P | 1 |
| Ruchirawat, S | 1 |
| Haswell-Elkins, M | 1 |
| Awacharagan, P | 1 |
| Wongratanacheewin, S | 3 |
| Levakhina, NM | 1 |
| Krivtsova, LA | 1 |
| Thammapalerd, N | 1 |
| Tharavanij, S | 1 |
| Nacapunchai, D | 1 |
| Prasertsiriroj, V | 1 |
| Viyanant, V | 2 |
| Brockelman, WY | 1 |
| Kurathong, S | 2 |
| Lee, P | 1 |
| Kraengraeng, R | 1 |
| Charupatana, C | 1 |
| Bychkov, VG | 1 |
| Molokova, OA | 1 |
| Zuevskiĭ, VP | 1 |
| Rattanasiriwilai, W | 1 |
| Priwan, R | 1 |
| Upatham, S | 1 |
| Jong, EC | 1 |
| Wasserheit, JN | 1 |
| Johnson, RJ | 1 |
| Carberry, WL | 1 |
| Agosti, J | 1 |
| Dunning, S | 1 |
| Clark, H | 1 |
| Lindecken, KD | 1 |
| Schulz, D | 1 |
| Engel, C | 1 |
| Siedek, M | 1 |
| Hengstmann, JH | 1 |
| Hsu, CC | 1 |
| Kron, MA | 1 |
| Wegner, DH | 1 |
11 reviews available for praziquantel and Opisthorchis felineus Infection
| Article | Year |
|---|---|
Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis.
Topics: Albendazole; Animals; Anthelmintics; China; Clonorchiasis; Fascioliasis; Humans; Network Meta-Analys | 2022 |
Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs.
Topics: Animals; Anthelmintics; Antioxidants; Drug Discovery; Drug Repositioning; Drug Therapy, Combination; | 2020 |
Risk Factors for Opisthorchis Viverrini Infection: A Systematic Review.
Topics: Adolescent; Adult; Animals; Anthelmintics; Asia, Southeastern; Case-Control Studies; Child; Child, P | 2020 |
Reservoir Animals and Their Roles in Transmission of Opisthorchis viverrini.
Topics: Animals; Disease Reservoirs; Ecosystem; Humans; Opisthorchiasis; Opisthorchis; Praziquantel; Thailan | 2018 |
[Opisthorchiasis: tradition and innovation].
Topics: Animals; Anthelmintics; Combined Modality Therapy; DNA, Helminth; Drug Therapy, Combination; Feces; | 2012 |
Association between praziquantel and cholangiocarcinoma in patients infected with Opisthorchis viverrini: a systematic review and meta-analysis.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Humans; O | 2013 |
The role of evolutionary biology in research and control of liver flukes in Southeast Asia.
Topics: Animals; Anthelmintics; Biological Evolution; Clonorchiasis; Clonorchis sinensis; Fasciola hepatica; | 2016 |
Opisthorchiidosis--a review.
Topics: Animals; Humans; Opisthorchiasis; Opisthorchis; Praziquantel | 2010 |
Clinical manifestation of opisthorchiasis and treatment.
Topics: Animals; Anthelmintics; Biliary Tract Diseases; Cholangiocarcinoma; Female; Humans; Liver Diseases, | 2003 |
Opisthorchiasis control in Thailand.
Topics: Animals; Anthelmintics; Food Parasitology; Health Education; Humans; Liver Diseases, Parasitic; Opis | 2003 |
Trematode infections. Opisthorchiasis, clonorchiasis, fascioliasis, and paragonimiasis.
Topics: Adult; Animals; Anthelmintics; Benzimidazoles; Clonorchiasis; Fascioliasis; Humans; Liver; Opisthorc | 1993 |
15 trials available for praziquantel and Opisthorchis felineus Infection
| Article | Year |
|---|---|
Public health interventions for preventing re-infection of Opisthorchis viverrini: application of the self-efficacy theory and group process in high-prevalent areas of Thailand.
Topics: Adult; Animals; Anthelmintics; Feces; Female; Humans; Male; Opisthorchiasis; Opisthorchis; Praziquan | 2021 |
Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Dru | 2018 |
Efficacious and safe dose of praziquantel for the successful treatment of feline reservoir hosts with opisthorchiasis.
Topics: Animals; Anthelmintics; Cat Diseases; Cats; Disease Reservoirs; Dose-Response Relationship, Drug; Fe | 2017 |
Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial.
Topics: Adult; Animals; Anthelmintics; Coinfection; Dose-Response Relationship, Drug; Female; Humans; Male; | 2017 |
[Effect of praziquantel and ursodeoxycholic acid therapy on bile lithogenicity in patients with opisthorchosis on the background of main variant of standard diet].
Topics: Anthelmintics; Bile; Cholagogues and Choleretics; Cholelithiasis; Diet; Drug Therapy, Combination; H | 2009 |
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
Topics: Adolescent; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Fema | 2011 |
Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial.
Topics: Adolescent; Animals; Anthelmintics; Child; Female; Humans; Laos; Male; Opisthorchiasis; Opisthorchis | 2012 |
A pilot project for controlling O. viverrini infection in Nong Wai, Northeast Thailand, by applying praziquantel and other measures.
Topics: Food Contamination; Humans; Isoquinolines; Opisthorchiasis; Opisthorchis; Pilot Projects; Praziquant | 1984 |
Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Isoquinolines; Male; Middle Aged; | 1980 |
Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Isoquinolines; Male; Midd | 1981 |
Field trials in the control of Opisthorchis viverrini with an integrated programme in endemic areas of northeast Thailand.
Topics: Animals; Anthelmintics; Cohort Studies; Feces; Food Handling; Health Education; Opisthorchiasis; Opi | 1993 |
Treatment of Opisthorchis viverrini and intestinal fluke infections with Praziquantel.
Topics: Adolescent; Adult; Aged; Animals; Antiplatyhelmintic Agents; Female; Humans; Intestinal Diseases, Pa | 1998 |
[Clinico-immunologic indicators in children with opisthorchiasis in relation to the use of various anthelmintics].
Topics: Adjuvants, Immunologic; Adolescent; Antiplatyhelmintic Agents; B-Lymphocytes; Child; Child, Preschoo | 1990 |
Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Child; Clinical Trials as Topi | 1985 |
Studies on the chemotherapy of human opisthorchiasis: effective dose of praziquantel in heavy infection.
Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Feces; Humans; Male; Opisthorchia | 1985 |
109 other studies available for praziquantel and Opisthorchis felineus Infection
| Article | Year |
|---|---|
R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini.
Topics: Adult; Animals; Anthelmintics; Child; Child, Preschool; Chromatography, Liquid; Humans; Laos; Opisth | 2022 |
Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
Topics: Antigens, Bacterial; Bacterial Proteins; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Fibrosis; Fo | 2022 |
High endemicity of Opisthorchis viverrini infection among people in northern Cambodia confirmed by adult worm expulsion.
Topics: Animals; Cambodia; Liver; Opisthorchiasis; Opisthorchis; Praziquantel | 2023 |
Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis.
Topics: Animals; Humans; Opisthorchiasis; Opisthorchis; Praziquantel; Rapid Diagnostic Tests; Sensitivity an | 2023 |
Effects of Opisthorchis viverrini infection on glucose and lipid profiles in human hosts: A cross-sectional and prospective follow-up study from Thailand.
Topics: Animals; Anthelmintics; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Follow-Up | 2020 |
Opisthorchis felineus genes differentially expressed under praziquantel shed light on the nature of tegument disruption and indicate the adaptive role of cGMP-dependent protein kinase.
Topics: Animals; Antiplatyhelmintic Agents; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation | 2020 |
Application of urine antigen assay to evaluate outcomes of praziquantel treatment and reinfection in opisthorchiasis in northeast Thailand.
Topics: Animals; Antigens, Helminth; Feces; Humans; Opisthorchiasis; Opisthorchis; Praziquantel; Prospective | 2020 |
Reduction of Reinfection Rates with Opisthorchis viverrini through a Three-Year Management Program in Endemic Areas of Northeastern Thailand.
Topics: Adult; Age Factors; Animals; Endemic Diseases; Female; Fishes; Food Parasitology; Health Education; | 2020 |
The impact of Opisthorchis felineus infection and praziquantel treatment on the intestinal microbiota in children.
Topics: Adolescent; Animals; Anthelmintics; Bacteria; Biodiversity; Case-Control Studies; Child; DNA, Bacter | 2021 |
Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
Topics: Adult; Animals; Anthelmintics; Bile Ducts, Intrahepatic; Case-Control Studies; Cholangiocarcinoma; D | 2021 |
Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Animals; Anthelmintics; Biomarkers; Cholangiocarcinoma; Chronic | 2018 |
Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro.
Topics: Animals; Anthelmintics; Clotrimazole; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; | 2018 |
Physicochemical Properties and Anti-Opisthorchosis Effect of Mechanochemically Synthesized Solid Compositions of Praziquantel with Glycyrrhizic Acid Disodium Salt.
Topics: Animals; Antiplatyhelmintic Agents; Biological Availability; Chemical Phenomena; Chemistry Technique | 2018 |
Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anthelmintics; Biliary Tract Diseases; Biomarkers; Deoxyguanos | 2019 |
A study of tribendimidine effects in vitro and in vivo on the liver fluke Opisthorchis felineus.
Topics: Animals; Anthelmintics; Cricetinae; Mesocricetus; Opisthorchiasis; Opisthorchis; Phenylenediamines; | 2019 |
Effects of supramolecular complexation of praziquantel with disodium glycyrrhizinate on the liver fluke Opisthorchis felineus: An in vitro and in vivo study.
Topics: Animals; Anthelmintics; Cricetinae; Disease Models, Animal; Glycyrrhizic Acid; Male; Mesocricetus; O | 2019 |
Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Bile Duct Neoplasms; Cholangiocarcinoma; Cro | 2019 |
Infection with Opisthorchis viverrini and use of praziquantel among a working-age population in northeast Thailand.
Topics: Adult; Aged; Animals; Anthelmintics; Cholangiocarcinoma; Cross-Sectional Studies; Diet; Feeding Beha | 2013 |
A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model.
Topics: Acanthaceae; Alanine Transaminase; Alkaline Phosphatase; Animals; Anthelmintics; Anti-Inflammatory A | 2013 |
[Experience of using reamberin for detoxification therapy at the stage of deworming in children with chronic opisthorchiasis].
Topics: Adolescent; Animals; Anthelmintics; Child; Chronic Disease; Erythrocyte Aggregation; Erythrocytes; F | 2013 |
Foodborne trematodiasis and Opisthorchis felineus acquired in Italy.
Topics: Animals; Anthelmintics; Female; Foodborne Diseases; Humans; Italy; Middle Aged; Opisthorchiasis; Opi | 2014 |
Perceived illness drives participation in mass deworming campaigns in Laos.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Cooking; Fasciolias | 2015 |
[A man in his thirties with icterus and itching].
Topics: Adult; Ancylostoma; Animals; Anthelmintics; Asia, Southeastern; Bile Ducts; Clonorchiasis; Clonorchi | 2014 |
The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cricetina | 2015 |
The first comprehensive study of praziquantel effects in vivo and in vitro on European liver fluke Opisthorchis felineus (Trematoda).
Topics: Animals; Anthelmintics; Disease Models, Animal; Histocytochemistry; Inhibitory Concentration 50; Loc | 2015 |
Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile | 2016 |
Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Bile Canaliculi; Cricetinae; Curcum | 2016 |
The Carcinogenic Liver Fluke Opisthorchis viverrini among Rural Community People in Northeast Thailand: a Cross- Sectional Descriptive Study using Multistage Sampling Technique.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Cross-Sectional Studies; | 2015 |
Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel.
Topics: Adult; Aged; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcino | 2016 |
Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Carcinogenesis; Cholangiocarcinoma; Cricetinae; Humans; | 2017 |
Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients.
Topics: Adult; Animals; Anthelmintics; Area Under Curve; Female; Half-Life; Humans; Male; Middle Aged; Molec | 2016 |
High excretion of etheno adducts in liver fluke-infected patients: protection by praziquantel against DNA damage.
Topics: Adult; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Ch | 2008 |
Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection.
Topics: Animals; Collagen; Cricetinae; Gene Expression Profiling; Hydroxyproline; Liver; Liver Cirrhosis; Ma | 2009 |
[Dynamics of pro-and anti-inflammatory cytokines at patients with combination of chronic opisthorchiasis with Helicobacter pylori-associated gastritis].
Topics: Anthelmintics; Chronic Disease; Cytokines; Female; Gastritis; Helicobacter Infections; Helicobacter | 2009 |
Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel.
Topics: alpha-Tocopherol; Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangioca | 2010 |
Copro-DNA diagnosis of Opisthorchis viverrini and Haplorchis taichui infection in an endemic area of Lao PDR.
Topics: Animals; Anthelmintics; Cross-Sectional Studies; DNA, Helminth; Feces; Heterophyidae; Humans; Laos; | 2010 |
Histopathological diagnosis of opisthorchiasis in an immigrant.
Topics: Animals; Anthelmintics; Emigrants and Immigrants; Female; Gallbladder Diseases; Germany; Humans; Kaz | 2010 |
Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis.
Topics: Animals; Anthelmintics; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cyclooxyg | 2012 |
Adult Opisthorchis viverrini flukes in humans, Takeo, Cambodia.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Cambodia; Cathartics; Cricetinae; Disease Reservoir | 2011 |
Message from Director General.
Topics: Animals; Anthelmintics; Clonorchiasis; Clonorchis sinensis; Communicable Disease Control; Humans; Op | 2012 |
A large outbreak of Opisthorchis felineus in Italy suggests that opisthorchiasis develops as a febrile eosinophilic syndrome with cholestasis rather than a hepatitis-like syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Cholestasis; Disease Outb | 2012 |
Activity of tribendimidine and praziquantel combination therapy against the liver fluke Opisthorchis viverrini in vitro and in vivo.
Topics: Animals; Cricetinae; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Inhibitory C | 2013 |
[The problem of opisthorchiasis in Ukraine and modern approaches to treatment].
Topics: Adolescent; Adult; Anthelmintics; Child; Female; Humans; Male; Opisthorchiasis; Praziquantel; Preval | 2012 |
Cryptic and asymptomatic Opisthorchis felineus infections.
Topics: Adult; Aged; Albendazole; Animals; Disease Outbreaks; DNA, Helminth; Dose-Response Relationship, Dru | 2013 |
[Complex therapy of chronic viral hepatitis, occurring in combination with opisthorchosis].
Topics: Anthelmintics; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interf | 2002 |
[Clinical picture, diagnosis and treatment of chronic opisthorchiasis].
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Chronic Disease; Diagnosis, Differential; Female; H | 2003 |
A case of Opisthorchis felineus infestation in a pilot from Greece.
Topics: Adult; Animals; Aviation; Follow-Up Studies; Greece; Humans; Male; Opisthorchiasis; Opisthorchis; Pr | 2003 |
Opisthorchiasis from imported raw fish.
Topics: Animals; Anthelmintics; Carps; Disease Outbreaks; Feces; Female; Humans; Male; Middle Aged; Opisthor | 2004 |
Mixed infections with Opisthorchis viverrini and intestinal flukes in residents of Vientiane Municipality and Saravane Province in Laos.
Topics: Adolescent; Adult; Aged; Anthelmintics; Child; Child, Preschool; Feces; Female; Food Parasitology; H | 2005 |
Field testing of the WHO dose pole for administration of praziquantel in the treatment of opisthorchiasis in Lao PDR.
Topics: Adolescent; Adult; Aged; Anthelmintics; Body Height; Body Weight; Child; Dose-Response Relationship, | 2007 |
Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel.
Topics: Animals; Anthelmintics; Apoptosis; Bile Ducts; Cricetinae; Gene Expression Regulation; Opisthorchias | 2007 |
Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment.
Topics: Animals; Anthelmintics; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Cricetinae; Gene Expressio | 2008 |
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Anthelmintics; Bile Duct Neoplasms; Bile | 2008 |
Liver procollagen prolyl hydroxylase in Opisthorchis viverrini infected hamsters after praziquantel administration.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Cricetinae; Isoqui | 1983 |
Evaluation of selected anthelmintic compounds for activity against Opisthorchis viverrini.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Benzodiazepinones; Cricetinae; Diphenylamine; F | 1984 |
Human trematode infections.
Topics: Anthelmintics; Asia, Southeastern; Bithionol; Clonorchiasis; Hexylresorcinol; Humans; Opisthorchiasi | 1984 |
Infection and re-infection rates of opisthorchiasis in the water resource development area of Nam Pong project, Khon Kaen Province, northeast Thailand.
Topics: Diet; Health Education; Humans; Opisthorchiasis; Praziquantel; Recurrence; Sanitation; Thailand; Tim | 1984 |
Opisthorchis viverrini: clinical experience with praziquantel in Hospital for Tropical Diseases.
Topics: Adult; Female; Humans; Isoquinolines; Male; Opisthorchiasis; Opisthorchis; Praziquantel | 1984 |
Roentgenographically controlled healing of gallbladder lesions in opisthorchiasis after praziquantel treatment.
Topics: Adult; Cholecystography; Common Bile Duct; Female; Gallbladder Diseases; Humans; Isoquinolines; Male | 1984 |
Therapeutic results in opisthorchiasis with praziquantel in a reinfection-free environment in France.
Topics: Adult; Child; Drug Tolerance; Female; France; Humans; Isoquinolines; Male; Opisthorchiasis; Parasite | 1984 |
Clonorchiasis/opisthorchiasis in South Carolina.
Topics: Adult; Clonorchiasis; Humans; Laos; Male; Opisthorchiasis; Parasite Egg Count; Praziquantel; South C | 1983 |
Liver collagen in Opisthorchis viverrini infected hamsters following praziquantel treatment.
Topics: Animals; Collagen; Cricetinae; Dose-Response Relationship, Drug; Isoquinolines; Liver; Opisthorchias | 1983 |
Clinical and laboratory evaluation of praziquantel in opisthorchiasis.
Topics: Adolescent; Adult; Aged; Female; Humans; Isoquinolines; Male; Middle Aged; Opisthorchiasis; Praziqua | 1983 |
Increased efficacy of liposomes-encapsulated praziquantel in treatment of opisthorchiasis in hamsters.
Topics: Animals; Cricetinae; Isoquinolines; Liposomes; Mesocricetus; Opisthorchiasis; Praziquantel | 1983 |
Alterations of the surface tegument of Opisthorchis viverrini exposed to praziquantel in vitro and in vivo.
Topics: Animals; Cricetinae; Cyprinidae; Humans; In Vitro Techniques; Isoquinolines; Microscopy, Electron, S | 1984 |
Mass treatment of opisthorchiasis in Northeast Thailand.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Isoquinolines; Male; Middle Aged; | 1982 |
Praziquantel compared to hexachloroparaxylol in the treatment of far eastern liver fluke infestation of man.
Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Female; Humans; Isoquinolines; Laos; Liver Diseases, P | 1982 |
[Study on the tolerability of high doses of praziquantel in Laotians with parasitic liver infections (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Humans; Isoquinolines; Laos; Liver Diseases, Parasitic; Male; Middle | 1981 |
[Treatment of severe Oriental hepatic distomiasis with praziquantel. Preliminary results in 30 patients].
Topics: Isoquinolines; Liver Diseases, Parasitic; Opisthorchiasis; Praziquantel | 1981 |
Chemotherapy of intestinal parasites in southeast asia.
Topics: Asia, Southeastern; Helminthiasis; Humans; Intestinal Diseases, Parasitic; Isoquinolines; Opisthorch | 1981 |
Field trial of praziquantel in human opisthorchiasis in Thailand.
Topics: Administration, Oral; Humans; Isoquinolines; Opisthorchiasis; Praziquantel; Thailand | 1981 |
High efficacy of praziquantel in the treatment of 22 patients with Clonorchis/Opisthorchis infections.
Topics: Adolescent; Adult; Animals; Body Fluids; Clonorchiasis; Drug Evaluation; Duodenum; Feces; Female; Hu | 1981 |
Praziquantel in clonorchiasis and opisthorchiasis.
Topics: Adolescent; Adult; Child; Clonorchiasis; Female; Humans; Isoquinolines; Male; Middle Aged; Opisthorc | 1981 |
Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis.
Topics: Adult; Animals; Bile Duct Neoplasms; Cholangiocarcinoma; Cross-Sectional Studies; Diet; Humans; Male | 1994 |
Clonorchiasis/opisthorchiasis in Malaysians case reports and review.
Topics: Animals; Clonorchiasis; Clonorchis sinensis; Female; Humans; Male; Metronidazole; Middle Aged; Opist | 1995 |
[Right-sided epigastric pain in a couple from Kasachstan].
Topics: Abdominal Pain; Adult; Animals; Bile; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Emigrati | 1995 |
Changes in serum antibodies to Opisthorchis viverrini in humans and hamsters following treatment of opisthorchiasis.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cricetinae; Dose-Response Relationship, Immunolog | 1994 |
Multi-infection with helminths in adults from northeast Thailand as determined by post-treatment fecal examination of adult worms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Echinostomiasis; Feces; Female; Helminthiasis; Hu | 1994 |
Pharmacokinetics of praziquantel in patients with opisthorchiasis.
Topics: Adult; Female; Humans; Liver; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Opi | 1993 |
Opisthorchiasis control in northeast Thailand: proposal for a new approach.
Topics: Animals; Cat Diseases; Cats; Disease Vectors; Dog Diseases; Dogs; Drug Administration Schedule; Fish | 1994 |
[The allergic deworming syndrome in opisthorchiasis].
Topics: Adolescent; Adult; Antibody Formation; Antiplatyhelmintic Agents; Chronic Disease; Drug Hypersensiti | 1993 |
Time-dependent modulation of liver lesion development in Opisthorchis-infected Syrian hamster by an antihelminthic drug, praziquantel.
Topics: Animals; Cocarcinogenesis; Cricetinae; Female; Liver; Liver Neoplasms; Mesocricetus; Nitrosamines; O | 1993 |
Serum antibody responses in opisthorchiasis.
Topics: Animals; Antibodies, Helminth; Antibody Formation; Antibody Specificity; Antiplatyhelmintic Agents; | 1995 |
Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection.
Topics: Adult; Analysis of Variance; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Huma | 1996 |
Cross-sectional patterns of hepatobiliary abnormalities and possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholelithiasis; Cross-Sect | 1996 |
Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini.
Topics: Analysis of Variance; Animals; Antiplatyhelmintic Agents; Aryl Hydrocarbon Hydroxylases; Bile Ducts, | 1996 |
Opisthorchis viverrini infection in Thailand: studies on the morbidity of the infection and resolution following praziquantel treatment.
Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Biliary Tract; Child; Child, Preschool; Feces; Female; | 1997 |
The impact of a decade long opisthorchiasis control program in northeastern Thailand.
Topics: Adolescent; Adult; Animals; Antiplatyhelmintic Agents; Child; Child, Preschool; Cooking; Fishes; Hea | 1997 |
Opisthorchiasis and intestinal fluke infections in northern Thailand.
Topics: Animals; Antiplatyhelmintic Agents; Humans; Intestinal Diseases, Parasitic; Opisthorchiasis; Praziqu | 1998 |
Modulation of dihydroxy-di-n-propylnitrosamine-induced liver lesion development in Opisthorchis-infected Syrian hamsters by praziquantel treatment in association with butylated hydroxyanisole or dehydroepiandrosterone administration.
Topics: Animals; Anthelmintics; Butylated Hydroxyanisole; Carcinogens; Chemoprevention; Cricetinae; Dehydroe | 1998 |
Affinity purified oval antigen for diagnosis of Opisthorchiasis viverrini.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Antibodies, Monoclonal; Antigens, Helminth; Chromatogr | 2001 |
Prevalence of Opisthorchis viverrini infection among villagers harboring Opisthorchis-like eggs.
Topics: Animals; Anthelmintics; Coloring Agents; Diagnosis, Differential; Feces; Heterophyidae; Humans; Opis | 2001 |
[Anthelmintic therapy of opisthorchiasis in patients with active tuberculosis].
Topics: Child; Humans; Interleukin-1; Monocytes; Opisthorchiasis; Praziquantel; Rosette Formation; T-Lymphoc | 1992 |
[Opisthorchis felineus--the cat liver fluke. Differential diagnosis of right-side upper abdominal pain].
Topics: Abdominal Pain; Animals; Clonorchis sinensis; Diagnosis, Differential; Female; Humans; Middle Aged; | 1992 |
Separation and characterization of adult worm proteins and glycoproteins from the liver fluke Opisthorchis viverrini.
Topics: Animals; Antigens, Helminth; Cricetinae; Electrophoresis, Polyacrylamide Gel; Feces; Glycoproteins; | 1992 |
Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential.
Topics: Animals; Body Weight; Cricetinae; Liver Diseases, Parasitic; Liver Neoplasms, Experimental; Male; Me | 1992 |
Opisthorchis viverrini: relationships between egg counts, worms recovered and antibody levels within an endemic community in northeast Thailand.
Topics: Animals; Antibodies, Helminth; Enzyme-Linked Immunosorbent Assay; Feces; Fertility; Humans; Immunogl | 1991 |
Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Feces; Female; Gallbladder; Humans; Liver; Male | 1989 |
A new intestinal fluke, Plagiorchis harinasutai n.sp.
Topics: Adult; Animals; Feces; Female; Humans; Male; Opisthorchiasis; Praziquantel; Trematoda | 1989 |
Detection of antibodies against Opisthorchis viverrini in patients before and after treatment with praziquantel.
Topics: Animals; Antibodies, Helminth; Concanavalin A; Enzyme-Linked Immunosorbent Assay; Hemagglutination T | 1988 |
Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy.
Topics: Age Factors; Humans; Opisthorchiasis; Praziquantel; Recurrence; Thailand; Time Factors | 1988 |
Transient rise in Opisthorchis egg count after praziquantel treatment.
Topics: Animals; Female; Humans; Middle Aged; Opisthorchiasis; Opisthorchis; Parasite Egg Count; Praziquante | 1988 |
Effect of praziquantel treatment on antibody levels and lymphoproliferative responses in patients with opisthorchiasis.
Topics: Animals; Antibodies, Helminth; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assa | 1988 |
[Granulomatous inflammation of the liver in opisthorchiasis].
Topics: Animals; Cricetinae; Dimethylnitrosamine; Female; Granuloma; Hydrocortisone; Liver; Mesocricetus; Op | 1987 |
Immunodepression in hamsters experimentally infected with Opisthorchis viverrini.
Topics: Animals; Antibody Formation; Cricetinae; Female; Immune Tolerance; Immunity, Cellular; Lymphocyte Ac | 1987 |
Clinical field trial of praziquantel in opisthorchiasis in Nong Rangya Village, Khon Kaen Province, Thailand.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Feces; Female; Humans; Male; Middle Aged; Opisthor | 1986 |
[Possibilities of surgical and drug therapy of parasitic cholestasis].
Topics: Amebiasis; Cholestasis; Combined Modality Therapy; Echinococcosis, Hepatic; Humans; Liver Abscess; M | 1985 |
Clonorchiasis and praziquantel.
Topics: Clonorchiasis; Feces; Humans; Isoquinolines; Opisthorchiasis; Praziquantel; Transients and Migrants | 1985 |
[Praziquantel in the treatment of opisthorchiasis in Southeast Asian refugees. Evaluation of 153 cases].
Topics: Adolescent; Adult; Aged; Asia, Southeastern; Child; Clonorchiasis; Female; France; Humans; Male; Mid | 1985 |